Headline News

In this video, J. Nicholas Bodor, MD, PhD, MPH, assistant professor in the department of hematology/oncology at Fox Chase Cancer, discusses the changing treatment landscape in EGFR-mutated lung cancer.

SAN ANTONIO — Obesity medications, regardless of class or generation, were associated with reduced alcohol intake among individuals participating in a telehealth weight-loss program, a speaker reported.

SAN DIEGO — Once-daily FXR314 was well-tolerated and safely improved liver fat content and biochemical markers over 16 weeks in patients with metabolic dysfunction-associated steatohepatitis, according to research at The Liver Meeting.

The FDA has accepted the resubmitted new drug application for reproxalap, an investigational treatment for dry eye disease, and assigned a Prescription Drug User Fee Act date, according to a press release from Aldeyra Therapeutics.

Laparoscopy may offer perioperative advantages to laparotomy and may be an acceptable alternative for some women with ovarian cancer, but systematic review and meta-analysis findings are limited by inclusion of only observational studies.

CHICAGO — In the BRAIN-AF trial, daily rivaroxaban did not reduce the incidence of cognitive decline, stroke or transient ischemic attack, compared with placebo, among younger patients with atrial fibrillation and low stroke risk.

BOSTON — Encouraging health-seeking behaviors could expedite recovery for patients with allergic rhinitis, according to a poster at the American College of Allergy, Asthma & Immunology Annual Scientific Meeting.

WASHINGTON — A focus on patient follow-up, standardized medication adherence and barriers assessments can reduce racial and ethnic disparities in juvenile idiopathic arthritis, according to a speaker at ACR Convergence 2024.

SAN DIEGO — Glucagon-like peptide-1 receptor agonists may help alleviate risk for adverse liver outcomes, particularly hepatic decompensation, among patients with type 2 diabetes and alcohol-associated liver disease.

BOSTON — Community engagement can help stock inhaler programs for underserved rural schools succeed, according to two posters presented at the American College of Allergy, Asthma & Immunology Annual Scientific Meeting.